Filing Flows › International Stem Cell (ISCO) › Q1 2026 › vs Q4 2025
International Stem Cell (ISCO) Q1 2026 vs Q4 2025 (quarter over quarter)
International Stem Cell's revenue rose $160K (+7%) from $2.2M in Q4 2025 to $2.3M in Q1 2026. The biggest changes: Biomedical Market +$170K (+8%); Anti Aging Skincare Market −$10K (-6%).
International Stem Cell, Q1 2026: revenue $2.3M (+9% year over year), operating margin -8.2%, net loss $220K, operating cash flow $121K. The chart draws each line against Q4 2025, the increases inside each band.
Margins
| Q1 2026 | Q4 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 4.2% | 1.3% | +2.9 pts |
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Biomedical Market | $2.2M | $2.0M | $170K | +8% |
| Anti Aging Skincare Market | $145K | $155K | −$10K | -6% |
| Revenue | $2.3M | $2.2M | $160K | +7% |
| Net loss | $220K | $348K | −$128K | -37% |
| Costs & expenses | $2.5M | $2.5M | $32K | +1% |
| Operating costs | $2.5M | $2.5M | $37K | +1% |
| Interest & other, net | $30K | $35K | −$5K | -14% |
| Cost of revenue | $954K | $1.1M | −$112K | -11% |
| Research & development | $156K | $177K | −$21K | -12% |
| Sales & marketing | $273K | $279K | −$6K | -2% |
| General & admin | $1.1M | $946K | $176K | +19% |
| Operating cash sources | $341K | $380K | −$39K | -10% |
| Depreciation & amortization | $34K | $54K | −$20K | -37% |
| Share-based compensation | $64K | $64K | $0 | 0% |
| Working capital & other | $243K | $262K | −$19K | -7% |
| Net loss absorbed | $220K | $348K | −$128K | -37% |
| Operating cash flow | $121K | $32K | $89K | +278% |
| Free cash flow (OCF − capex) | $98K | $29K | $69K | +238% |
| Capital expenditures | $23K | $3K | $20K | +667% |
Questions
How much did International Stem Cell's revenue grow quarter over quarter in Q1 2026?
International Stem Cell's revenue rose $160K (+7%) from $2.2M in Q4 2025 to $2.3M in Q1 2026.
What drove International Stem Cell's revenue change in Q1 2026?
Biomedical Market +$170K (+8%); Anti Aging Skincare Market −$10K (-6%).